|

SWA (standardized root extract of Withania somnifera) Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Tata Memorial Centre1

Indications

  • GVHD - Graft-Versus-Host Disease1
  • Hematopoietic Stem Cell Transplant (HSCT)1
  • Hematological Malignancy1
  • Cancer1

Other1 trial

Study to Evaluate the Safety and Effectiveness of Withaferin A as a Treatment to Prevent GvHD in Transplant Patients
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.